Corrigendum: The association between metabolic disturbance and cognitive impairments in early-stage schizophrenia

Corrigendum: The association between metabolic disturbance and cognitive impairments in early-stage schizophrenia

Bibliographic Details
Main Authors:	Xing-Jie Peng, Gang-Rui Hei, Ran-Ran Li, Ye Yang, Chen-Chen Liu, Jing-Mei Xiao, Yu-Jun Long, Ping Shao, Jing Huang, Jing-Ping Zhao, Ren-Rong Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Human Neuroscience
Subjects:	metabolic disturbance MCCB early-stage schizophrenia cognitive impairment correlation–regression analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fnhum.2022.1094810/full

Similar Items

The Association Between Metabolic Disturbance and Cognitive Impairments in Early-Stage Schizophrenia
by: Xing-Jie Peng, et al.
Published: (2021-02-01)

Corrigendum: The association between cognitive deficits and clinical characteristic in first-episode drug naïve patients with schizophrenia
by: Xing-Jie Peng, et al.
Published: (2022-12-01)

Corrigendum: The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia
by: Xing-Jie Peng, et al.
Published: (2021-04-01)

The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia
by: Xing-Jie Peng, et al.
Published: (2021-02-01)

Amplitude of low-frequency fluctuation (ALFF) may be associated with cognitive impairment in schizophrenia: a correlation study
by: Pengshuo Wang, et al.
Published: (2019-01-01)

Relationships between abnormal neural activities and cognitive impairments in patients with drug-naive first-episode schizophrenia
by: Wei Yan, et al.
Published: (2020-06-01)

Effect of Virtual Reality on Cognitive Impairment and Clinical Symptoms among Patients with Schizophrenia in the Remission Stage: A Randomized Controlled Trial
by: Shangda Li, et al.
Published: (2022-11-01)

Identifying and revealing different brain neural activities of cognitive subtypes in early course schizophrenia
by: Tiannan Shao, et al.
Published: (2022-10-01)

Correlation Between Resting Theta Power and Cognitive Performance in Patients With Schizophrenia
by: Yanxiang Cao, et al.
Published: (2022-04-01)

The difference of social cognitive and neurocognitive performance between patients with schizophrenia at different stages and influencing factors
by: Shengyun Chen, et al.
Published: (2021-06-01)

The Category Fluency Test components and their association with cognition and symptoms in adolescents with schizophrenia
by: Rogelio Apiquian, et al.
Published: (2024-03-01)

Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
by: Zhuo K, et al.
Published: (2019-05-01)

Cognitive Dysfunctions Measured with the MCCB in Deficit and Non-Deficit Schizophrenia
by: Piotr Plichta, et al.
Published: (2023-03-01)

Sex differences in association between cognitive impairment and clinical correlates in Chinese patients with first-episode drug-naïve schizophrenia
by: Na Zhao, et al.
Published: (2021-04-01)

Core of sensory gating deficits in first-episode schizophrenia: attention dysfunction
by: Yushen Ding, et al.
Published: (2023-04-01)

The Chinese Brief Cognitive Test: Normative Data Stratified by Gender, Age and Education
by: Shuling Ye, et al.
Published: (2022-07-01)

Emotional Processing Profile in Patients with First Episode Schizophrenia: The Influence of Neurocognition
by: Verónica Romero-Ferreiro, et al.
Published: (2022-04-01)

The Relationship Between Abnormal Resting-State Functional Connectivity of the Left Superior Frontal Gyrus and Cognitive Impairments in Youth-Onset Drug-Naïve Schizophrenia
by: Xiaolei Qiu, et al.
Published: (2021-10-01)

Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
by: Jing Huang, et al.
Published: (2020-06-01)

Corrigendum: rTMS induces brain functional and structural alternations in schizophrenia patient with auditory verbal hallucination
by: Yuanjun Xie, et al.
Published: (2023-01-01)

Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study
by: Wei Zheng, et al.
Published: (2020-11-01)

Retention and impairment of neurocognitive functions in mild cognitive impairment and Alzheimer’s disease with a comprehensive neuropsychological test
by: Lu Yao, et al.
Published: (2022-06-01)

The Relationship between Cognitive Functions and Psychopathological Symptoms in First Episode Psychosis and Chronic Schizophrenia
by: Katarzyna Rek-Owodziń, et al.
Published: (2022-05-01)

Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
by: Jing Huang, et al.
Published: (2020-05-01)

The MATRICS Consensus Cognitive Battery: Psychometric Properties of the Chinese Version in Young Patients With Major Depression Disorder
by: Sixiang Liang, et al.
Published: (2021-10-01)

The Role of Adiponectin in the Pathogenesis of Metabolic Disturbances in Patients With Schizophrenia
by: Cynthia Yi-An Chen, et al.
Published: (2021-01-01)

Negative Symptom Domains Are Associated With Verbal Learning in Adolescents With Early Onset Psychosis
by: Lynn Mørch-Johnsen, et al.
Published: (2022-01-01)

Cognitive deficits profiles in the first-episode of schizophrenia, clinical high risk of psychosis, and genetically high-risk of psychosis
by: Fang Dong, et al.
Published: (2023-12-01)

rTMS Induces Brain Functional and Structural Alternations in Schizophrenia Patient With Auditory Verbal Hallucination
by: Yuanjun Xie, et al.
Published: (2021-09-01)

Associations between metabolic disorders and sleep disturbance in patients with schizophrenia
by: Huiming Yan, et al.
Published: (2023-04-01)

Cannabis use and cognitive impairment in schizophrenia
by: M. Gonçalves, et al.
Published: (2022-06-01)

Interrelation of visual and olfactory impairments in schizophrenia
by: M. Tumova, et al.
Published: (2021-04-01)

The role of the insula in cognitive impairment of schizophrenia
by: Susanna Gebhardt, et al.
Published: (2023-06-01)

Associations of cognitive impairment in patients with schizophrenia with genetic features and with schizophrenia-related structural and functional brain changes
by: Chuanjun Zhuo, et al.
Published: (2022-08-01)

Cognitive functioning in patients treated with electroconvulsive therapy
by: Kalisova L, et al.
Published: (2018-11-01)

Impaired age self-consciousness in latent schizophrenia
by: R. Suleimanov, et al.
Published: (2021-04-01)

Cognitive impairments in schizophrenia and their impact on oxidative stress
by: A. S. Piatoikina, et al.
Published: (2022-10-01)

Correlation of Sleep Disturbance and Cognitive Impairment in Patients with Parkinson’s Disease
by: Eun Ja Kim, et al.
Published: (2014-04-01)

Cognitive impairment in treatment-refractory schizophrenia and type i diabetes. A case
by: L. Soldado Rodriguez, et al.
Published: (2021-04-01)

Increased Plasma Kynurenic Acid Levels are Associated with Impaired Attention/Vigilance and Social Cognition in Patients with Schizophrenia
by: Huang X, et al.
Published: (2020-01-01)